Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
12/2001
12/26/2001CN1327849A Composite Chinese medicine for treating lung diseases
12/26/2001CN1327846A Medicine for treating throat diseases and its preparing process
12/26/2001CN1327822A Universal red Zn-base ointment for treating injury and its prparing process
12/26/2001CN1327821A Capsule for treating cough and asthma
12/26/2001CN1327809A Process for preparing antitussive mixture
12/26/2001CN1327805A Chinese medicine 'Chuncao Xiongbitong' for treating asthma
12/26/2001CN1327799A Mixture of white pepper and borneol and its application
12/26/2001CN1076624C Nasally administrable compositions
12/26/2001CN1076618C Liquid medicine for treating wound and pain and preparing process thereof
12/26/2001CN1076616C Pure natural health-care article for eliminating smoke harm
12/25/2001US6333361 Pharmaceutical composition containing zafirlukast
12/25/2001US6333354 Synergistic combination of PDE inhibitors and adenylate cyclase agonists or guanyl cyclyse agonists
12/25/2001US6333341 Tumor necrosis factor, antiinflammatory agents and analgesics
12/25/2001US6333334 Use of macrolide compounds for the treatment of ARDS
12/25/2001CA2217950C Metered dose inhaler for albuterol
12/25/2001CA2184582C Pharmaceutically acceptable dnase formulation
12/20/2001WO2001096547A2 Human kinases
12/20/2001WO2001096546A2 Protein phosphatases
12/20/2001WO2001096397A2 Cd154 variants and uses thereof
12/20/2001WO2001096385A1 Codon optimised recombinant dermaphagoides allergens
12/20/2001WO2001096336A2 6,5-fused bicyclic heterocycles
12/20/2001WO2001096331A1 Lactam inhibitors of factor xa and method
12/20/2001WO2001096330A2 Thrombin receptor antagonists
12/20/2001WO2001096323A1 Serine protease inhibitors
12/20/2001WO2001096305A1 Serine protease inhibitors
12/20/2001WO2001096302A1 Piperidines for use as orexin receptor antagonists
12/20/2001WO2001096299A2 Indole derivatives and their use as 15-lipoxygenase inhibitors
12/20/2001WO2001096298A2 1,2,4-trisubstituted benzenes as inhibitors of 15-lipoxygenase
12/20/2001WO2001096296A1 Serine protease inhibitors
12/20/2001WO2001095939A1 Novel solid dispersion compositions
12/20/2001WO2001095932A1 A COMBINATION PRODUCT COMPRISING MELAGATRAN AND A FACTOR VIIa INHIBITOR
12/20/2001WO2001095925A1 Pharmaceutical anti-inflammatory aerosol formulation
12/20/2001WO2001095910A1 Imidazopyridine and imidazopyrimidine antiviral agents
12/20/2001WO2001095903A1 5-ht3 receptor antagonists for treatment of disorders involving airway constriction
12/20/2001WO2001095902A1 A composition comprising a combination of receptor agonists and antagonists
12/20/2001WO2001095886A1 Bioavailable dosage form of isotretinoin
12/20/2001WO2001095885A1 Dry-powder pharmaceutical formulation for inhalation comprising alpha4-intergrin antagonist
12/20/2001WO2001095883A1 Novel pharmaceutical formulation suitable for nebulisation
12/20/2001WO2001095882A1 Novel aqueous anti-inflammatory pharmaceutical formulation
12/20/2001WO2001095881A1 Pharmaceutical anti-inflammatory aerosol formulation
12/20/2001WO2001095880A1 Novel pharmaceutical formulation suitable for nebulisation
12/20/2001WO2001095879A1 Novel aqueous anti-inflammatory pharmaceutical formulation
12/20/2001WO2001095785A2 Modulation of immune response and methods based thereon
12/20/2001WO2001062933A3 Muteins of interleukin-13 (il-13)
12/20/2001WO2001058896A8 Benzoxazole derivatives as tnf and pde iv inhibitors
12/20/2001WO2001049689A3 NOVEL SUBSTITUTED PYRAZOLO[4,3-e]DIAZEPINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, USE AS MEDICINAL PRODUCTS AND PROCESSES FOR PREPARING THEM
12/20/2001WO2001048208A3 Streptococcus pyogenes virulence genes and proteins and their use
12/20/2001WO2001039745A3 Aerosol composition comprising formoterol
12/20/2001WO2001031016A3 Processed human chemokines phc-1 and phc-2
12/20/2001US20010053782 Pyrrolo[2,3-d]pyrimidine compounds
12/20/2001US20010053763 Method and composition for modulating an immune response
12/20/2001US20010053758 Methods and compositions for the treatment and prevention of lung disease
12/20/2001US20010053351 Inhibition of GSK-3 beta
12/20/2001CA2412462A1 6,5-fused bicyclic heterocycles
12/20/2001CA2412327A1 Imidazopyridine and imidazopyrimidine antiviral agents
12/20/2001CA2412216A1 Lactam inhibitors of factor xa and method
12/20/2001CA2411805A1 Serine protease inhibitors
12/20/2001CA2411798A1 Serine protease inhibitors
12/20/2001CA2411495A1 1,2,4-trisubstituted benzenes as inhibitors of 15-lipoxygenase
12/20/2001CA2411472A1 Cd154 variants
12/20/2001CA2411231A1 Codon optimised recombinant dermaphagoides allergens
12/20/2001CA2411116A1 Indole derivatives and their use as 15-lipoxygenase inhibitors
12/20/2001CA2410610A1 Human kinases
12/20/2001CA2410228A1 A combination product comprising melagatran and a factor viia inhibitor
12/20/2001CA2409315A1 Protein phosphatases
12/20/2001CA2382065A1 Bioavailable dosage form of isotretinoin
12/19/2001EP1164145A2 Non-anticoagulant desulfated heparins as medicaments
12/19/2001EP1163910A1 Preventives/remedies for interstitial pneumonia and pulmonary fibrosis
12/19/2001EP1163909A2 Use of sugar ethers as immunity adjuvant in vaccine compositions, therapeutic compositions containing them and their use as vaccine
12/19/2001EP1163904A1 Composition for the prevention of smooth muscle diseases comprising ascorbate, arginine and magnesium
12/19/2001EP1163523A1 Method for detecting predisposition to a venous thromboembolic disease
12/19/2001EP1163356A1 Retroviral vectors comprising functional and non-functional splice donor and splice acceptor sites
12/19/2001EP1163342A1 Chlamydia antigens and corresponding dna fragments and uses thereof
12/19/2001EP1163336A2 Vertebrate protein slit, dna sequence encoding it and uses thereof
12/19/2001EP1163335A1 MATERIALS AND METHODS RELATING TO MODULATION OF p66 EXPRESSION
12/19/2001EP1163333A2 Inhibitors of endothelin-1 synthesis
12/19/2001EP1163332A1 48 human secreted proteins
12/19/2001EP1163267A1 47 human secreted proteins
12/19/2001EP1163242A2 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
12/19/2001EP1163239A1 Modified amino-acid amides as cgrp antagonists
12/19/2001EP1163238A1 Chemokine recpetor binding heterocyclic compounds
12/19/2001EP1163237A1 Amide derivatives
12/19/2001EP1163236A1 Aromatic heterocyclic compounds as anti-inflammatory agents
12/19/2001EP1163227A1 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, and processes for preparing them
12/19/2001EP1163226A1 Polysubstituted 6-phenylphenanthridines with pde-iv inhibiting activity
12/19/2001EP1163213A1 Hydroxamic and carboxylic acid derivatives
12/19/2001EP1163212A1 Amide derivatives
12/19/2001EP1163003A1 Treatment of lfa-1 associated disorders with increasing doses of lfa-1 antagonist
12/19/2001EP1163000A2 Vaccine against antigens from bacteriae
12/19/2001EP1162999A2 Vaccine against Streptococcus pneumoniae
12/19/2001EP1162998A2 Vaccine against streptococcus pneumoniae capsular polysaccharides
12/19/2001EP1162990A1 Treatment with small peptides to effect antifibrotic activity
12/19/2001EP1162983A1 Vaccine for house dust mite allergen using naked plasmid dna
12/19/2001EP1162970A2 Anti-inflammatory uses of manzamines
12/19/2001EP1162964A1 Treatment of pulmonary hypertension
12/19/2001EP1094816A4 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
12/19/2001EP0828742B1 Diazepino-indoles as phosphodiesterase iv inhibitors
12/19/2001EP0785781B1 Use of indole derivatives for the treatment of dermatological disorders peripheral neuropathied, arthritis, allergic or chronic obstructive airways disease, glaucoma and ocular inflammation
12/19/2001EP0707849B1 Use of derivatives of 2,4-disubstituted phenols as 5-lipoxigenase inhibitors
12/19/2001CN1327452A Fibroblast growth factor with hepatocyte proliferation activity